An interesting round up of the Top 10 Sequencing Companies from Genetic Engineering & Biotechnology News highlights the dominance of Illumina on the life-sciences (genomics) industry.

Illumina’s $2.752 billion in 2017 is almost double the combined revenue of the other 9 companies ($1.445 billion).

With giants like Grail and Human Longevity, as well as a very healthy research community and a rapidly growing diagnostics community, Illumina look to have a good future ahead of them!

The Top 10 “sequencing” companies:

#1. Illumina $2.752 billion in 2017

#2. Thermo Fisher Scientific “Just under” $418.36 million in 2017

#3. BGI Genomics $332.3 million

#4. Agilent Technologies approximately $230 million

#5. Qiagen More than $115 million

#6. Macrogen $95.4 million

#7. PacBio $93.5 million

#8. Genewiz $83.1 million

#9. 10x Genomics $71 million

#10. Oxford Nanopore Technologies $6.3 million